Dana Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Hold |
11,855
| – | – | ﹤0.01% | 535 |
|
|
2025
Q1 | $102K | Hold |
11,855
| – | – | ﹤0.01% | 538 |
|
|
2024
Q4 | $127K | Hold |
11,855
| – | – | ﹤0.01% | 537 |
|
|
2024
Q3 | $67.3K | Hold |
11,855
| – | – | ﹤0.01% | 531 |
|
|
2024
Q2 | $50K | Hold |
11,855
| – | – | ﹤0.01% | 522 |
|
|
2024
Q1 | $60.3K | Hold |
11,855
| – | – | ﹤0.01% | 522 |
|
|
2023
Q4 | $110K | Hold |
11,855
| – | – | 0.01% | 419 |
|
|
2023
Q3 | $77.7K | Hold |
11,855
| – | – | ﹤0.01% | 405 |
|
|
2023
Q2 | $96.4K | Buy |
11,855
+1,170
| +11% | +$9.51K | ﹤0.01% | 390 |
|
|
2023
Q1 | $91.6K | Hold |
10,685
| – | – | ﹤0.01% | 395 |
|
|
2022
Q4 | $98.9K | Hold |
10,685
| – | – | 0.01% | 398 |
|
|
2022
Q3 | $110K | Hold |
10,685
| – | – | 0.01% | 390 |
|
|
2022
Q2 | $107K | Hold |
10,685
| – | – | 0.01% | 404 |
|
|
2022
Q1 | $132K | Buy |
+10,685
| New | +$132K | 0.01% | 337 |
|